FFA drug
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| hyperinsulinemia | interacts_with | FFA | — | 1 |
| insulin | regulates | FFA | — | 1 |
| PPARA | interacts_with | FFA | — | 1 |
| tesaglitazar | regulates | FFA | — | 1 |
Mentioned in (2)
Papers in which this entity is mentioned.
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. (2016)
- The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat. (2013)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ffa | drug | 2 | 4 |